OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
62
Results
Show all
Save search
Copy query
Show results for
Unknown
(60)
Genomics
(2)
Organisms
Homo sapiens
(2)
Repository
EGA
(2)
Technology Type
Illumina MiSeq, ILLUMINA
(1)
Publication Date
Release Date
2021
(15)
2022
(10)
2024
(6)
2020
(6)
2023
(5)
2025
(4)
2018
(4)
2019
(3)
2016
(2)
2009
(2)
2017
(1)
2015
(1)
2014
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?
Not available
S-EPMC6478380
|
biostudies-literature
Cite
ena-DATASET-LUDJHU-22-08-2017-18:25:45:667-381 - samples
Samples prepared using Safe-SeqS technology. All samples ran on an Illumina MiSeq instrument. Fastq files for read 1 and the index read present (R and I respectively).
EGAD00001003579
|
EGA
Cite
Targeting
HER2
Aberrations in Non-Small Cell Lung Cancer with Osimertinib.
Not available
S-EPMC6434713
|
biostudies-literature
Cite
Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB-mediated inflammatory response in Triple Negative Breast Cancer.
Not available
S-EPMC12458326
|
biostudies-literature
Cite
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling.
Not available
S-EPMC7549316
|
biostudies-literature
Cite
Octopaminergic neurons have multiple targets in
Drosophila
larval mushroom body calyx and can modulate behavioral odor discrimination.
Not available
S-EPMC7812863
|
biostudies-literature
Cite
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.
Not available
S-EPMC9437561
|
biostudies-literature
Cite
EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas.
Not available
S-EPMC10274685
|
biostudies-literature
Cite
EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.
Not available
S-EPMC10863487
|
biostudies-literature
Cite
MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer.
Not available
S-EPMC8812775
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets